Skip to main content
Caplight Logo









Regemat 3D

Regemat 3D

Private
GranadaHealthcare & Life Scienceshttps://www.regemat3d.com/

Last Round

Crowdfunding

May 31, 2022

Est. Valuation

$19.47M

Total Funding Raised

$1.86M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Regemat 3D is a biotechnology company that develops and provides customizable 3D bioprinters, bioreactors, and biomaterials for tissue engineering and regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, 3D Printing, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

3D bioprintersbioprintingtissue engineeringregenerative medicinebioreactorsbiofabrication platformbiomaterialsbioinkstissue maturationorgan printingcustomizable bioprintersfunctional tissuescell-laden scaffoldsbioprinting softwareturnkey lab setup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Regemat 3D Comparables

Compare Regemat 3D with similar companies based on industry and business-model similarity.

Regemat 3D comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Allevi
86%
RegenHU
85%
Poietis
83%

Regemat 3D Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingMay 31, 2022
CrowdfundingOct 20, 2020

Key People

Founding team and executive leadership

José Manuel Baena

President & CEO, Biofabrication And Cell Culture Lab Director

Executive Team

Regemat 3D Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 11, 69% of headcount.

  • Jul 13, 2026

    Open roles increased from 0 to 10, representing 63% of headcount.

Regemat 3D Filings

Explore SEC and related filing metadata, where available.

Regemat 3D filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Regemat 3D's valuation, stock price, and market status.

Is Regemat 3D a public or private company?

Regemat 3D is a private company.

What is the current stock price of Regemat 3D?

Regemat 3D is a private company with no public stock price. No recent secondary market data is available.

How much is Regemat 3D worth (valuation)?

Regemat 3D's valuation is estimated at $19.5M based on funding round data.

Can I buy Regemat 3D stock?

Regemat 3D shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Regemat 3D's last funding round?

Regemat 3D's most recent funding round was Crowdfunding on May 31, 2022.

Who are the main investors in Regemat 3D?

Key investors in Regemat 3D include Horizon 2020, Center for Technological Development and Innovation.

Will Regemat 3D IPO soon?

No public IPO plans have been announced for Regemat 3D.

How can I track Regemat 3D secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Regemat 3D's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGranada
Employee Range12
Year Founded2015
Last FundingMay 31, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?